Financials
- Market Capitalization 767.42 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.13
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2615 | DBVT DBV Technologies S.A. - American Depositary Shares | 13.54 USD | -6.04% | -5.18% | +0.89% | +42.98% | 801.73 M USD | ||
| 2637 | NVCT Nuvectis Pharma, Inc. - Common Stock | 23.73 USD | -5.80% | +0.72% | +10.01% | +265.08% | 773.16 M USD | ||
| 2657 | MNPR Monopar Therapeutics Inc. - Common Stock | 111.89 USD | -1.80% | +4.60% | +3.27% | +104.85% | 751.02 M USD | ||
| 2667 | PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.18 USD | +2.68% | +3.38% | +4.91% | -23.37% | 742.67 M USD |